Oral administration of acetylcholine receptor: Effects on experimental myasthenia gravis

Annals of Neurology

Volumn 36, Issue 5, 1994, Pages 704-713

  Okumura, Seiichi ^a,b   McIntosh, Kevin ^a   Drachman, Daniel B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY; CHOLINERGIC RECEPTOR ANTIGEN; INTERLEUKIN 2; KEYHOLE LIMPET HEMOCYANIN; OVALBUMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; INTRADERMAL DRUG ADMINISTRATION; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; MYASTHENIA GRAVIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SPLEEN CELL; SUPPRESSOR CELL; T LYMPHOCYTE; TORPEDO CALIFORNICA;

ADMINISTRATION, ORAL; ANIMAL; DESENSITIZATION, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; FEMALE; MYASTHENIA GRAVIS; OVALBUMIN; RATS; RATS, INBRED LEW; RECEPTORS, CHOLINERGIC; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES;

EID: 0028075630     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410360504     Document Type: Article

References (42)

1. Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors
2. Autoimmune response to acetylcholine receptor
3. Myasthenia gravis and related disorders
4. Long‐term corticosteroid treatment of myasthenia gravis
5. Myasthenia gravis: discontinuation of long‐term azathioprine
6. Possible strategies for the treatment of myasthenia gravis and other autoimmune diseases
7. Myasthenia gravis
8. Orally induced tolerance
9. The regulation of immune responses to dietary protein antigens
10. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments
11. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein
12. Inhibition of Santigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S‐antigen
13. Suppression of experimental autoimmune uveitis in rats by the oral administration of the uveitopathogenic S‐antigen fragment or a crossreactive homologous peptide
14. Suppression of type II collagen‐induced arthritis by intragastric administration of soluble type II collagen
15. Suppression of collagen‐induced arthritis with pergastrically or intravenously administered type II collagen
16. Double‐blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis
17. Effects of oral administration of type II collagen on rheumatoid arthritis
18. Experimental autoimmune myasthenia gravis: cellular and humoral aspects
19. Acetylcholine receptor‐specific human T‐lymphocyte lines
20. Purification and molecular properties of the acetylcholine receptor from Torpedo eletroplax
21. Tolerance to acetylcholine receptor induced by AChR‐coupled syngeneic cells
22. Combined short‐term immunotherapy cures experimental autoimmune myasthenia gravis
23. Antigen‐specific suppressor macrophages induced by culture with cyclosporin A plus acetylcholine receptor
24. T cell vaccination in experimental myasthenia gravis. A double‐edged sword
25. Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs
26. Enterically induced immunological tolerance. I Induction of suppressor lymphocytes by intragastric administration of soluble proteins
27. Immunologic suppression after oral administration of antigen. I. Specific suppressor cells found in rat Peyer's patches after oral administration of sheep erythrocytes, and their systemic migration
28. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein
29. Studies on the chemistry of anaphylaxis (III). Experiments with isolated proteins, especially those of the hen's egg
30. Could specific oral tolerance be a therapy for autoimmune disease?
31. Antigen‐driven peripheral immune tolerance
32. Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor
33. Inhibition of specific immune responses by feeding protein antigens. III. Evidence against maintenance of tolerance to ovalbumin by orally induced antibodies
34. Immune responses of guinea pigs to dietary protein
35. Molecular weight in detergent solution of acetylcholine receptor from orpedo californica
36. Oral tolerance in experimental autoimmune encephalomyelitis: serum and salivary antibody responses
37. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen
38. The influence of oral immunization on local and systemic immune responses to heterologous antigens
39. MS study yields mixed results
40. Oral tolerance in experimental autoimmune encephalomyelitis
41. Inhibition of specific immune responses by feeding protein antigens. II. Effects of prior passive and active immunization
42. Flare‐up of antigen‐induced arthritis in mice after challenge with oral antigen